| Trademark Snap Shot ITU Unit Action (Table presents the data on ITU Unit Action) |
|||
OVERVIEW |
|||
| SERIAL NUMBER | 85442528 | FILING DATE | 10/07/2011 |
| REG NUMBER | 0000000 | REG DATE | N/A |
| REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
| INTL REG # | N/A | INTL REG DATE | N/A |
| TM ATTORNEY | DELANEY, ZHALEH SYBIL |
L.O. ASSIGNED | 116 |
PUB INFORMATION |
|||
| RUN DATE | 08/10/2012 | ||
| PUB DATE | 03/20/2012 | ||
| STATUS | 730-FIRST EXTENSION - GRANTED | ||
| STATUS DATE | 08/09/2012 | ||
| LITERAL MARK ELEMENT | CERULEAN | ||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A | ||
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
| 1 (b) | YES | 1 (b) | YES | 1 (b) | NO |
| 44D | NO | 44D | NO | 44D | NO |
| 44E | NO | 44E | NO | 44E | NO |
| 66A | NO | 66A | NO | ||
| NO BASIS | NO | NO BASIS | NO | ||
MARK DATA |
|
| STANDARD CHARACTER MARK | YES |
| LITERAL MARK ELEMENT | CERULEAN |
| MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
| COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 20-OWNER AT PUBLICATION |
| NAME | Cerulean Pharma Inc. |
| ADDRESS | 840 Memorial Drive, 5th Floor Cambridge, MA 02139 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Delaware |
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION TEXT | pharmaceutical preparations for use in the diagnosis, prognosis or prevention of oncological diseases or disorders, including malignant cancers or neoplasms; pharmaceutical preparations for use in the diagnosis, prognosis, prevention or treatment of oncological diseases or disorders, including pre-cancerous diseases or disorders and benign cancers or neoplasms, inflammation and inflammatory diseases or disorders, and cardiovascular diseases or disorders; pharmaceutical preparations for use in modulating angiogenesis; pharmaceutical preparations for use in the diagnosis, prognosis and prevention of oncological diseases or disorders, including malignant cancers or neoplasms, all containing nanometer size compounds which facilitate targeting or delivery of the active ingredient; pharmaceutical preparations for use in the diagnosis, prognosis, prevention or treatment of oncological diseases or disorders, including pre-cancerous diseases or disorders and benign cancers or neoplasms, inflammation and inflammatory diseases or disorders, and cardiovascular diseases or disorders, all containing nanometer size compounds which facilitate targeting or delivery of the active ingredient; pharmaceutical preparations for use in modulating angiogenesis, containing nanometer size compounds which facilitate targeting or delivery of the active ingredient |
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
| PARENT OF | |
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 08/10/2012 | EXRA | O | NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED | 016 |
| 08/10/2012 | NOAC | O | CORRECTED NOA MAILED | 015 |
| 08/09/2012 | EX1G | S | EXTENSION 1 GRANTED | 014 |
| 07/24/2012 | EXT1 | S | EXTENSION 1 FILED | 013 |
| 08/09/2012 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | 012 |
| 07/24/2012 | DRRR | I | DIVISIONAL REQUEST RECEIVED | 011 |
| 08/07/2012 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | 010 |
| 07/24/2012 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | 009 |
| 07/24/2012 | EEXT | I | TEAS EXTENSION RECEIVED | 008 |
| 05/15/2012 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | 007 |
| 03/20/2012 | PUBO | A | PUBLISHED FOR OPPOSITION | 006 |
| 02/29/2012 | NPUB | O | NOTICE OF PUBLICATION | 005 |
| 01/31/2012 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | 004 |
| 01/25/2012 | DOCK | D | ASSIGNED TO EXAMINER | 003 |
| 10/14/2011 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
| 10/11/2011 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | David Ehrlich |
| CORRESPONDENCE ADDRESS | DAVID EHRLICH FROSS ZELNICK LEHRMAN & ZISSU, P.C. 866 UNITED NATIONS PLZ NEW YORK, NY 10017-1822 |
| DOMESTIC REPRESENTATIVE | NONE |
PRIOR OWNER INFORMATION |
|
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | Cerulean Pharma Inc. |
| ADDRESS | 840 Memorial Drive, 5th Floor Cambridge, MA 02139 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Delaware |